glycine has been researched along with Dyslipidemia in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Muraglitazar is a non-thiazolidinedione, oxybenzylglycine dual PPARalpha/gamma agonist that is in advanced clinical development for the treatment of type 2 diabetes and its associated dyslipidemia." | 6.43 | Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia. ( Cox, SL, 2005) |
| "Muraglitazar is a non-thiazolidinedione, oxybenzylglycine dual PPARalpha/gamma agonist that is in advanced clinical development for the treatment of type 2 diabetes and its associated dyslipidemia." | 2.43 | Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia. ( Cox, SL, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Handzlik, MK | 1 |
| Gengatharan, JM | 1 |
| Frizzi, KE | 1 |
| McGregor, GH | 1 |
| Martino, C | 1 |
| Rahman, G | 1 |
| Gonzalez, A | 1 |
| Moreno, AM | 1 |
| Green, CR | 1 |
| Guernsey, LS | 1 |
| Lin, T | 1 |
| Tseng, P | 1 |
| Ideguchi, Y | 1 |
| Fallon, RJ | 1 |
| Chaix, A | 1 |
| Panda, S | 1 |
| Mali, P | 1 |
| Wallace, M | 1 |
| Knight, R | 1 |
| Gantner, ML | 1 |
| Calcutt, NA | 1 |
| Metallo, CM | 1 |
| Venkatesh, R | 1 |
| Srinivasan, K | 1 |
| Singh, SA | 1 |
| Yue, JT | 1 |
| Mighiu, PI | 1 |
| Naples, M | 1 |
| Adeli, K | 1 |
| Lam, TK | 1 |
| Cox, SL | 1 |
1 review available for glycine and Dyslipidemia
| Article | Year |
|---|---|
Muraglitazar: an agent for the treatment of type 2 diabetes and associated dyslipidemia.
Topics: Adult; Aged; Animals; Area Under Curve; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Drug Th | 2005 |
3 other studies available for glycine and Dyslipidemia
| Article | Year |
|---|---|
Insulin-regulated serine and lipid metabolism drive peripheral neuropathy.
Topics: Adiposity; Animals; Diabetes Mellitus, Experimental; Diet, High-Fat; Dyslipidemias; Glycine; Insulin | 2023 |
Effect of arginine:lysine and glycine:methionine intake ratios on dyslipidemia and selected biomarkers implicated in cardiovascular disease: A study with hypercholesterolemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Arginine; Biomarkers; Body Weight; Cardiovascular Diseas | 2017 |
Glycine normalizes hepatic triglyceride-rich VLDL secretion by triggering the CNS in high-fat fed rats.
Topics: Adiponectin; Animals; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Dietary Fats; Dyslipidemias; Fat | 2012 |